Adela, Inc.
New Form D on file · 2026-04-23 · the record
Adela, Inc. filed a Form D with the Securities and Exchange Commission on 2026-04-23.
Adela, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 23, 2026. Adela, Inc. was formerly named DNAMx, Inc. The filing reports $5M sold. Its industry group is Biotechnology. It names Lisa Alderson (Executive Officer, Director), David Bonita (Director), Paul Brown (Director) (SEC Form D, April 23, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Adela, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-04-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Adela, Inc.
Free to see. No signup.
More on the people and the money behind Adela, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in April 2026, largest first.
Get an email when Adela, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Adela, Inc. raises, hires or launches. No email unless you switch it on.
Watch Adela, Inc. →Get the full cited report on Adela, Inc.
What the filing shows about Adela, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Adela, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Adela, Inc.'s address as 353 Hatch Drive, Foster City, CA 94404.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Adela, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Adela, Inc. is a registered filer with the SEC (CIK 1852167) and has filed since 2023-08-11. 5 filings are on record, the latest on 2026-04-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Adela, Inc.'s Form D of 2026-04-23 names Lisa Alderson, David Bonita, Paul Brown and 9 more as its officers, directors or promoters.
Its new offerings report $62.95M sold across 5 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $5M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can address the unmet need broadly across multiple cancers and applications.
The title and description the site itself served, answering 200, after redirecting from https://adelabio.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Lisa Alderson is named as Executive Officer and Director on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
David Bonita is named as Director on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Paul Brown is named as Director on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Daniel Diniz De Carvalho is named as Executive Officer on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Abraham Kometz is named as Director on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Anne-Renee Hartman is named as Executive Officer on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Maneesh Jain is named as Director on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
David Scheer is named as Executive Officer and Director on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Robert Weisskoff is named as Director on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Alan Williams is named as Executive Officer on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Scott Bratman is named as Executive Officer on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
Lindsay Mateo is named as Executive Officer on the Form D that Adela, Inc. filed with the SEC on 23 April 2026, one of 12 people that filing names.
12 people named on the filing — 7 holding an executive role and 5 as directors only.
Named as of the 2026-04-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Adela, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Adela, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Adela, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Adela, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Adela, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (adelabio.com).
Each opens in a new tab, filled in for Adela, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/adela-inc-form-d-26000001